| (210) | Number of the EPO application | 22176524 |
| (220) | Filing date of the EPO application | 2016.06.29 |
| (80) | EPO patent specification publication (B) | EPB nr. 09/2023, 2023.03.01 |
| (110) | EPO patent number | 4070787 |
| (21) | Number of the application | e 2022 1140 |
| (71) | Name(s) of applicant(s), code of the country | Gilead Sciences, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | KOZIARA Joanna M., US;
MCCALLISTER Scott, US; |
| (73) | Name(s) of owner(s), code of the country | GILEAD Sciences Inc., US; |
| (54) | Title of the invention | PHARMACEUTICAL FORMULATIONS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 9/20 (2006.01.01); A61K 9/24 (2006.01.01); A61K 31/513 (2006.01.01); A61K 31/675 (2006.01.01); A61K 9/00 (2006.01.01); A61K 9/28 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2022.11.30 |
| (30) | Priority | 201562187113 P, 2015.06.30, US; 201662298373 P, 2016.02.22, US; 201662301429 P, 2016.02.29, US; 201662317286 P, 2016.04.01, US |